Revance Therapeutics, Inc. (RVNC)
TN
Total Compensation for Fiscal Year Ending in 2022: $6,606,916
| Salary | $673,200 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $4,178,690 |
| Value of Option Awards | $1,099,525 |
| Non-Equity Incentive Plan Compensation | $640,870 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $14,631 |
| Total | $6,606,916 |
Revance Therapeutics, Inc. disclosed its CEO pay was
30
times its median employee's pay for the fiscal year ending in 2022.
How Do You Compare?
